Seizures clinical trials in Connecticut
4 studies for Seizures are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Yale University, New Haven
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 2, 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Yale University, New Haven
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 1, 2026 · NCT06798896Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
- Yale New Haven Hospital, New Haven
Recruiting
Ages 19 to 85 · All sexes · Updated Sep 21, 2026 · NCT05784805A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Yale School of Medicine - Yale-New Haven Hospital, New Haven
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.